Clinical Trial Update: Dose Escalation Study of EG110A, Administered by Intradetrusor Injections to Adults With Neurogenic Detrusor Overactivity-related Incontinence Following Spinal Cord Injury Who Regularly Perform Clean Intermittent Catheterization [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 dose-escalation study of EG110A delivered via intradetrusor injections for neurogenic detrusor overactivity related to spinal cord injury; currently r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurogenic Detrusor Overactivity
• Spinal Cord Injury

Drugs mentioned

• EG110A

Snippet

Sponsor: EG 427 | Conditions: Neurogenic Detrusor Overactivity, Spinal Cord Injuries | Phase 1, Phase 2 | Status: RECRUITING